LANSING, Mich., July 22, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, today announced the launch of its entirely new website, www.kraiglabs.com.
"Although we've worked with cutting-edge biotech companies in the past, our whole team was fascinated by the incredible things Kraig Biocraft is achieving in the labs," commented Jonathan Keim, owner of GPGSolutions. "We truly enjoyed working with the Company and being a part of its exciting story."
"As we move toward the commercialization of recombinant spider silks, it is important that we build our band and our image," said Company CEO and founder, Kim K Thompson. "With Jonathan's help, we built a website from the ground up, to better highlight the Company's high-tech foundations and enhance our public image. The new and improved website is also part of our plan to improve communication with prospective partners, customers and our shareholders. We hired GPGSolutions' because of their stellar reputation and their enthusiasm for the project. Their creativity, responsiveness and technical ability worked to produce a platform that better represents our vision and promotes our brand."
Shareholders and interested persons who have not already done so, are invited to subscribe to the Company's email updates in advance of the launch of that program. The sign in button can be found at the bottom of the Investors page of the Company website.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc